Search

You searched for "laser"

1302 results found

Blaedderwaerc and other names

1 July 2016 | | URO - Infection, URO - Functional / Reconstructive Urology, URO - Technology
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). In the last article I said I would explore the history of something...

Metabolic screening and stone-prevention in urolithiasis patients

1 July 2017 | | URO - Endourology & Stones
The incidence and prevalence of kidney stones is increasing [1,2]. Significant recurrence rates are noted with 14% of patients experiencing a further episode at one year, 35% at five years, and 52% at 10 years [3]. Over 10% of stone...

Impact of adjuvant radiation therapy on urinary continence recovery after radical prostatectomy

1 January 2015 | | URO - Urologic Oncology
The functional side-effects of both radical prostatectomy and radiotherapy for prostate cancer are well known. The aim of this study was to evaluate if there was a significant worsening in recovery of urinary continence in those undergoing radical prostatectomy followed...
The Journal of Urology book cover with Editor's Choice stamp.

‘Born in the USA’ – neonatal circumcision

5 May 2021 | | URO - Paediatric Urology
In 2006, the British Association of Paediatric Urologists (BAPU) published a statement paper on the management of foreskin conditions (www.baps.org.uk/resources/management-foreskin-conditions). Non-therapeutic circumcisions (those to comply with religious or cultural practices) are not uniformly available on the NHS. Circumcisions for medical...

Post CCT fellowship in genitourethral reconstruction at St George’s Hospital: an experience unique to the UK

1 July 2018 | | URO - Core Urology
I first developed an interest in genitourethral reconstruction, particularly urethroplasty, at the beginning of my urology training. Working in Bristol and Weston Super Mare for David Dickerson inspired me to develop this further. Mr Dickerson performs one of the largest...

The assessment and medical treatment of LUTS secondary to BPH

1 November 2016 | URO - Functional / Reconstructive Urology
The term benign prostatic hyperplasia (BPH) describes prostate enlargement due to non-cancerous processes. Several aetiological mechanisms are involved, including hormonal and vascular alterations; abnormal regulation of apoptosis; and prostatic inflammation, which may stimulate cellular proliferation. With ageing, prostate enlargement can...

ICS updates in continence care: a personal perspective on the role of basic science in urology

1 March 2017 | | URO - Basic Science Research, URO - Functional / Reconstructive Urology
At a urology research meeting in Sheffield a few years ago, a former post doctorate researcher in urology, Mathieu Boudes, said: “Stop calling it basic research, there is nothing basic about it. It is fundamental research to everything urologists do.”...

Renal calculi composition – Hounsfield units or dual energy CT?

1 July 2014 | | URO - Endourology & Stones, URO - Uroradiology
In this, the inaugural uro-radiology article, Jane Belfield (Section Editor) considers the significance of Hounsfield units in defining stone composition. Despite its widespread adoption and referencing in stone MDTs, there are some very clear limitations. Jane explores the potential role...

Demanding cases or nightmares in uro-oncology? Sep/Oct 2022

5 September 2022 | | URO - Urologic Oncology
Treatment of prostate cancer in renal transplant recipients is challenging due to a lack of knowledge of the natural history of cancer in these patients, the anatomical position of the graft in the iliac fossa and its proximity to the...

BPH Focus

BPH Focus 2023 To skip directly to features, click the links below: Welcome from the editor- by Feras Al Jaafari Needs must, is it time for a major rethink for men with symptomatic BPH? An update from the GIRFT Academy-...

In conversation with James Green

3 October 2023 | URO - Core Urology
We were delighted to catch up with James Green, Consultant Urological Surgeon and new President of the Royal Society of Medicine Section of Urology. Can you tell us a little bit about what led you into the field of urology...

Recent advances in the management of castration resistant prostate cancer

1 November 2017 | | URO - Urologic Oncology
Castrate resistant prostate cancer (CRPC) is defined by disease progression despite androgen-deprivation therapy lowering testosterone to castrate levels. It may present as a rise in serum levels of prostate specific antigen (PSA), progression of pre-existing disease, or the appearance of...